The site will be unavailable in 58 minutes for scheduled maintenance.

Neostem Inc (NASDAQ:NBS)

CAPS Rating: 3 out of 5

Recs

6
Player Avatar GasparOP (< 20) Submitted: 3/14/2011 12:48:13 PM : Outperform Start Price: $15.77 NBS Score: -109.65

Neostem is making serious medical progress in an area that is right now cutting-edge and will later be commonplace, fitting my investment philosophy completely, It uses adult stem cells, which is encouraged by Catholic social teaching (the Vatican has a $1 million stake in the company).

Also, it has Chinese exposure, but it isn't totally dependent on them. It's making good acquisitions and being patient. Profitable within two-three years; stock could rise tenfold.

Member Avatar GasparOP (< 20) Submitted: 3/22/2011 12:40:16 PM
Recs: 2

Watch for a jump near or in November, when a Vatican conference co-sponsored by NBS will take place and raise public awareness of this Micro Cap.

Featured Broker Partners


Advertisement